Physician profile
Feng Gao
NPI 1578183638
$11,073.95
in general payments reported to CMS, 2019-2025
20 companies · $6,951 in 2025
The $6,951 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $811 · 2024: $3,312 · 2025: $6,951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,300 · Travel and Lodging: $3,774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,300.08 |
| Travel and Lodging | $3,773.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,444.74 | 2023-2025 | Micra, Corevalve Evolut R, Advisa Dr Mri Surescan |
| Abbott Laboratories | $2,882.01 | 2024-2025 | Gallant, Perclose Prostyle, Cardiomems |
| Biosense Webster, INC. | $1,247.58 | 2024-2025 | Carto 3 |
| Boston Scientific Corporation | $406.61 | 2023-2025 | Watchman Flx, Watchman, Farapulse |
| Actelion Pharmaceuticals US, INC. | $383.60 | 2024-2025 | Opsumit, Uptravi |
| Amgen INC. | $275.28 | 2024-2025 | Repatha, Repatha |
| Pfizer INC. | $202.61 | 2023-2024 | |
| Angiodynamics, INC. | $197.29 | 2024 | Alphavac |
| Abiomed | $152.30 | 2024-2025 | Impella |
| Livanova USA, INC. | $151.68 | 2023 | Tandemheart |
| Bolton Medical INC | $139.50 | 2023 | Treo Abdominal Stent-Graft System |
| Bridgebio Pharma, INC. | $139.46 | 2025 | Attruby |
| Terumo Medical Corporation | $126.45 | 2023 | Glidesheath Slender, Tr Band, Glidewire |
| Edwards Lifesciences Corporation | $101.80 | 2024-2025 | |
| Astrazeneca Pharmaceuticals Lp | $69.32 | 2024-2025 | Wainua |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $44.43 | 2025 | |
| Cvrx, INC. | $28.38 | 2025 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $27.94 | 2024 | Xarelto |
| Cardiva Medical, INC. | $27.55 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Lexicon Pharmaceuticals, INC. | $25.42 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Feng Gao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.